Leveron&Nexovas
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1589  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3741    
    Printed90    
    Emailed1    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 

 
Year : 1997  |  Volume : 45  |  Issue : 4  |  Page : 240--243

Sodium valproate monotherapy and sex hormones in men.


Department of Neurology, King George's Medical College, Lucknow - 226 003, India

Correspondence Address:
D Nag
Department of Neurology, King George's Medical College, Lucknow - 226 003
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 29513282

Rights and PermissionsRights and Permissions

Antiepileptic drugs affect various endocrinal functions including sex hormones. In this study, the effect of sodium valproate monotherapy on sex hormones has been evaluated in sexually asymptomatic patients of primary generalised tonic clonic epilepsy. Twenty-six newly diagnosed young male patients with epilepsy and twenty controls were subjects in this study. Sodium valproate monotherapy (20-30 mg/kg) was administered in patients to control the seizures. None of the patients had recurrence of seizure during one year of follow up. Serum levels of sodium valproate, total serum testosterone, leutinizing hormone (LH), follicle stimulating hormone (FSH) were estimated initially, before starting valproate therapy. These were repeated at 3 month intervals for one year. Patients on sodium valproate therapy showed minor changes in serum sex hormone level. The total testosterone level fell significantly (p<0.05) at the end of 1 year, however LH, FSH and serum prolactin levels remained unaltered. It was concluded that sodium valproate has potential for altering balance of testosterone after prolonged administration.






[PDF Not available]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow